chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in both of the upper shoulder muscles beginning 24 hours after the 3rd Pfizer booster shot. The pain has slowly progressed over the course of 17 days and has changed in nature of the pain and discomfort also during that same time frame.  There is some tightening on both sides of the upper back like a rubber band pulling the muscles that radiate down from the very top shoulder muscles towards the shoulder blade on both sides but is definitely more prominent on the left side. The doctor has thus far a regimen of prednisone cortisone tablets with no positive affect yet but I am only on the 2nd day of that medicine plan. I experience relief from the discomfort if I sit back in a soft chair or lay down. Sitting upright, standing, and some arm movements seem to trigger the flareups of tightening and pain. I have some loss of sensory touch across the top shoulder muscles but can feel pressure and pain in those areas ok. The sensory loss is related it seems to just the light touch.  I had the seasonal influenza vaccination on the same day as the 3rd booster shot but I do not have the formal medical descriptive information for that specific vaccination.
Rash around mouth; Swollen lips; Spotty rash on neck, arms, under arms, buttocks, and thighs. Rash on arms, buttocks, and thighs are not itchy; This is a spontaneous report from a contactable consumer (patient). A 53-Year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, lot unknown: True, Lot unknown reason: Unable to locate or read the details), dose 2 via an unspecified route of administration, administered in Left Arm on 14Jun2021 11:00 AM (at the age of 53-Year-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included Hypertension, high cholesterol, GERD. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. There were no known allergies. Concomitant medication(s) (in two weeks) included amlodipine taken for an unspecified indication, start and stop date were not reported; pantoprazole taken for an unspecified indication, start and stop date were not reported; calcium taken for an unspecified indication, start and stop date were not reported; vitamin b complex (VITAMIN B) taken for an unspecified indication, start and stop date were not reported; ascorbic acid (VITAMIN C) taken for an unspecified indication, start and stop date were not reported; colecalciferol (VITAMIN D) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Historical Vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot unknown: True, Lot unknown reason: Unable to locate or read the details), dose 1 via an unspecified route of administration, administered in Left Arm on 24May2021 11:00 AM (at the age of 53-Year-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient experienced rash around mouth (non-serious) on 15Jun2021 15:00 PM, swollen lips (non-serious) on 15Jun2021 15:00 PM, spotty rash on neck, arms, under arms, buttocks, and thighs. rash on arms, buttocks, and thighs are not itchy (non-serious) on 15Jun2021 15:00 PM. Adverse event:  Rash around mouth with swollen lips (but able to eat with a little discomfort). Spotty rash on neck, arms, under arms, buttocks, and thighs. Rash on arms, buttocks, and thighs are not itchy. Treatment was received for the adverse events (Currently, using Aveeno and applying ointment). Facility type vaccine was Pharmacy or Drug Store. Facility in Country. Adverse event country. The outcome of events was recovering.  Information about lot/batch number has been requested.
1.1/14/2021- first dose Pfizer COV19 vaccine injection     - day#1- left arm (injection arm) feel soreness and ache     - day#2- feel entire back/neck aching, entire left side down to my toes feel pain. Headache and nausea, feverish      - day#3- feel entire back/neck aching, entire left side down to my toes feel pain. Headache and nausea, feverish, plus irregular heart beat      - day#4- feel entire back/neck aching, entire left side down to my toes feel pain. Headache and nausea, feverish intensified      - day #5- body ache subsided, Headache and nausea continued to feel intensified. Fever now turn into chills      - day#6- unbearable headache and worse nausea feeling, chills, need to leave work in the afternoon. Throwed up and shaking. Took many headache medications and antinausea medications but nothing work.  2. 2/5/2021 @1630- received 2nd dose Pfizer COVID 19 vaccine      - day#1, 1 hour into receiving vaccine, feeling dizzy and "hangover" type reaction. 2 hours into receiving vaccine, developed irregular heart beats. Left arm injection pain and sore arm.      - day# 2: entire body ache, joint pain, headache and nausea      - day#3: severe headache and feeling nauseous. Took many headache and antinausea medications.       - will continue to follow adverse reactions.
Deltoid with erythema, warmth, tenderness to palpation. Treated for cellulitis with antibiotics.
Sore arm, headaches,  body aches, chills, fever, acidity, burning of eyes
Soreness of left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of left arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Urticaria.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness of left arm). At the time of the report, PAIN IN EXTREMITY (Soreness of left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow-up information included no new information.
Presyncopal next morning followed by shaking for hours. Arm increasingly sore with fever to 102.9.  Abdominal pain and headache. Syncopal each am for 4 days, fever continued for 4 days in 100 to 101 range after first day. arm pain for 6 days. Shaking lasted 2 days as did abd. pain and headache. Was in bed first 2 days and weak next 2 days.
Tingling sensation; Light headedness; Papular rash; Burning sensation; Feeling hot and cold; Chest tightness; Throat tightness; Chills; rapid heart rate; difficulty in breathing; metallic taste in her mouth; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Apr-2021 and was forwarded to Moderna on 22-Apr-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of HEART RATE INCREASED (rapid heart rate), DYSPNOEA (difficulty in breathing), DYSGEUSIA (metallic taste in her mouth), PARAESTHESIA (Tingling sensation) and DIZZINESS (Light headedness) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Penicillin allergy. Concomitant products included LIOTHYRONINE SODIUM, LEVOTHYROXINE and TAFLUPROST (ZIOPTAN) for an unknown indication.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jan-2021, the patient experienced HEART RATE INCREASED (rapid heart rate), DYSPNOEA (difficulty in breathing) and DYSGEUSIA (metallic taste in her mouth). On an unknown date, the patient experienced PARAESTHESIA (Tingling sensation), DIZZINESS (Light headedness), RASH PAPULAR (Papular rash), BURNING SENSATION (Burning sensation), FEELING OF BODY TEMPERATURE CHANGE (Feeling hot and cold), CHEST DISCOMFORT (Chest tightness), THROAT TIGHTNESS (Throat tightness) and CHILLS (Chills). On 02-Jan-2021, HEART RATE INCREASED (rapid heart rate), DYSPNOEA (difficulty in breathing) and DYSGEUSIA (metallic taste in her mouth) had resolved. At the time of the report, PARAESTHESIA (Tingling sensation), DIZZINESS (Light headedness), RASH PAPULAR (Papular rash), BURNING SENSATION (Burning sensation), FEELING OF BODY TEMPERATURE CHANGE (Feeling hot and cold), CHEST DISCOMFORT (Chest tightness), THROAT TIGHTNESS (Throat tightness) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was treated with Immediate- Bedadryl (unknown dosage), Pepcid40mg, Prednisone 40mg. Ongoing- Prednisone 5mg daily, Pepcid 20mg daily, Claritin 10mg daily.   This case was linked to US-MODERNATX, INC.-MOD-2021-087081 (E2B Linked Report).; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded. US-MODERNATX, INC.-MOD-2021-087081:case for dose 2
Hospitalized (11.5.21);  COVID-19 positive (11.5.21); fully vaccinated PLUS booster  Admission Date: 11/5/2021 Discharge Date: 11/6/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Elevated troponin [R77.8] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE:   85 yo M hx CAD, HLD, NHL, T2DM presented to ER on 11/5 with several days of fatigue, weakness, poor mobility, shortness of breath and cough. He had recently received his COVID19 booster shot approximately 2 weeks ago. On arrival to ER he is found to be hypoxic and placed on supplemental oxygen. His COVID19 PCR came back positive. CXR showed groundglass patchy opacities that could be of viral etiology. A CT Abdomen was obtained due to vague complaints of gastrointestinal issues, this imaging test was unremarkable. Labs were also unremarkable. Patient was admitted to Medicine service for further management of COVID19 pneumonia. He was started on decadron. Over the course of the following day, patient's symptoms improved drastically, particularly after initiation of steroids. His fatigue, abdominal pain, shortness of breath were resolved. He was able to wean from oxygen to room air and maintained his saturations. PT and OT recommended home with assist and home care. Patient is discharging home to complete 3 more days of decadron, during which time he has been advised to take 4 additional units of long acting insulin. Home health services will be set up. He will follow up with his primary care physician.
Pt was initially admitted 2/12 for 3-day history of bilateral hand and feet numbness as well as generalized weakness and chest discomfort. She had a flu like infection 4 weeks PTA. COVID positive 2/20. Hospital course was complicated by Covid pneumonia with superimposed Haemophilus influenzae bacterial pneumonia and acute hypoxic respiratory failure requiring intubation and vasopressors.  Infectious disease followed the patient and initially treated her with baricitinib, cefepime and Decadron.  Out of Covid isolation and continued to receive cefepime. Pt xtubated on 2/25. Pt was discharged with 3 L O2 on 3/18.
This spontaneous report was received from a healthcare worker refers to a 50 year old female patient. The patient persistent medical history included enlarged lymph nodes. The patient had hay fever allergy. On 09-APR-2014, the patient was vaccinated with ZOSTAVAX (lot # J012660, 0.65 ml once, subcutaneous. On 09-APR-2014 (also reported as immediately after receiving ZOSTAVAX) the patient experienced muscular rash, flat at the injection site. The reporter stated that the physician gave the patient BENADRYL and had her hold an ice pack over it for 20 minutes. The reporter also stated that one of the girls in the office called the patient later that evening and the patient said that the rash was gone. It was reported that this was the second time a muscular rash occurred with this lot number J012660. The outcome of the event was reported as recovering. The reporter did not provided the causality between the event and the suspect drug. This case is linked to the case 1404USA010321 (same reporter link). Additional information has been requested.
Information has been received from a doctor of pharmacy and a consumer concerning a 83 year old female patient with drug reactions or allergies to erythromycin, FELDENE, MOTRIN, FOSAMAX (WAES # 1205USA04952), CELEBREX and high blood pressure and high cholesterol who on 17-MAY-2012, was vaccinated with a dose of ZOSTAVAX (Merck), 0.65 ml, subcutaneously (lot number 671662/1160AA, expiration date 18-OCT-2012). There was no concomitant medication. On 17-MAY-2012, since receiving ZOSTAVAX (Merck), the patient had been very tired, dragging and exhausted. The patient was so tired she had to cancel her plans for the day. The pharmacist also reported that the patient had injection site redness "the size of a half dollar". There was no treatment given for being very tired, dragging and exhausted and injection site redness "the size of a half dollar". At the time of the report the patient not recovered. The patient sought medical attention, called the pharmacy. Follow up information has been received from the physician concerning the patient. The physician reported that he prescribed but he did not administer the vaccine. The physician stated that he was not aware of any adverse effect. The patient had a history of swollen arm while on prior therapy with PNEUMOVAX 23 (manufacturer unknown) (WAES # 1205USA04951). No further information is available.
Pt complained of freezing cold cramp in her right foot arch started about 1/2 hour after her 2nd vaccination.  Hot and burning with extreme cold started around 4/7/21 Other symptoms reactions started closer to 4/10/2021 blurred vision, "nerves" are flared up, achy, asthma really bad, "horrific pain", losing body strength.  Most of these reactions started 4/10/2021. Talked to normal medical provider with concerns problems were due to coronovirus vaccine  stated that it was just her nerves and not vaccine related. Pt went to a new provider, on 4/14 for an initial visit there.  She was still  having above symptoms and did not feel well at all and had extremely high blood pressure,  pt was told by this secondary medical provider to contact Public Health to report her side effect symptoms and thought symptoms were due to Coronovirus shots. pt permission to talk to nurse at Medical Center. (She was not a very good historian and said to call nurse and verify dates and labs).  Pt thought she only had a couple of days to live before she went in to be seen at the doctor.
pt recv vax & w/in 1wk pt exp 50-100 lesions & fever;
Information has been received on 26 SEP 2001 from a consumer concerning his wife who on 9 JUL 2001 was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (manufacturer unknown). The patient had an unusual soreness within the first week. The patient also felt feverish but her temperature was a degree or 2 low. On 26 SEP 2001 it was reported that the patient was still experiencing the problems. The patient sought unspecified medical attention. The reporter was also vaccinated and had similar symptoms (WAES01093033). Additional information has been requested.
H1N1 1st dose given @local pharmacy (nasal mist) Oct 2009. H1N1 2nd dose given @ local pharm (nasal mist) Nov 2009. Father unaware above doses obtained at a sick visit - 3rd dose H1N1 injection given to thigh on 2-1-2010. Leg red, hot, painful and swollen seen @ ER.
REDNESS, SWELLING, WARM, PRURITUS OF INJECTION SITE OF LEFT DELTOID AREA OF 7CM DIAMETER
Upset stomach 2 days after 1st COVID vaccine shot; This is a spontaneous report received from a non-contactable consumer (Patient). A 33-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on an unknown date in  Mar2021 (Batch/Lot Number: ER2613) at the age of 33-years-old as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The patient experienced upset stomach 2 days after 1st covid vaccine shot on an unknown date in Mar2021. The outcome of the event unknown.  No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a patient who on unspecified date was vaccinated with ZOSTAVAX (Merck) (lot # not reported). It was reported that the patient went into heart failure shortly after administration of ZOSTAVAX (Merck). The outcome of the event was not reported. Upon internal review, heart failure was considered to be an other important medical event. Additional information has been requested.
PATIENT RECEIVED VACCINE PAST BUD, CONSIDERED AS AN INVALID DOSE . PATIENT STATED NOT EXPERIENCING ANY ADVERSE EVENTS AND WILL COME BY WHEN HAVE TIME FOR RE-VACCINATING
Information has been received from a medical assistant concerning a 31 year old female who on 16-MAR-2007 was vaccinated with Gardasil (Lot #656049/0187U), intramuscular, in the left deltoid.  On 16-MAR-2007 the patient experienced shortness of breath beginning 2 hours after the vaccination.  It lasted a couple hours and then resolved without treatment.  Additional information has been requested.
2 inch swollen at the left arm; swollen lymph node under the left armpit; chills; body aches; redness at injection site; fever; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (2 inch swollen at the left arm), LYMPHADENOPATHY (swollen lymph node under the left armpit), CHILLS (chills), MYALGIA (body aches) and VACCINATION SITE ERYTHEMA (redness at injection site) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 427M21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fish allergy, Sulfonamide allergy and Allergy to antibiotic (Ciprofloxacin).    On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (2 inch swollen at the left arm), LYMPHADENOPATHY (swollen lymph node under the left armpit), CHILLS (chills), MYALGIA (body aches), VACCINATION SITE ERYTHEMA (redness at injection site) and PYREXIA (fever). At the time of the report, SWELLING (2 inch swollen at the left arm), LYMPHADENOPATHY (swollen lymph node under the left armpit), CHILLS (chills), MYALGIA (body aches) and VACCINATION SITE ERYTHEMA (redness at injection site) had not resolved and PYREXIA (fever) had resolved.            No relevant concomitant medications were reported. Treatment information was unknown.
Injection site itchy; Had a burning knot on left arm at injection; Injection site was sore; Injection site puffy and hard; Diarrhea; Chills; Vomiting; Fever; Rash on face on over body (left breast, chest and back); This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE INDURATION (Had a burning knot on left arm at injection), CHILLS (Chills) and VOMITING (Vomiting) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), CHILLS (Chills), VOMITING (Vomiting), PYREXIA (Fever) and RASH (Rash on face on over body (left breast, chest and back)). On 08-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE INDURATION (Had a burning knot on left arm at injection), VACCINATION SITE PAIN (Injection site was sore) and VACCINATION SITE SWELLING (Injection site puffy and hard). At the time of the report, DIARRHOEA (Diarrhea), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE INDURATION (Had a burning knot on left arm at injection), CHILLS (Chills), VOMITING (Vomiting), PYREXIA (Fever), RASH (Rash on face on over body (left breast, chest and back)), VACCINATION SITE PAIN (Injection site was sore) and VACCINATION SITE SWELLING (Injection site puffy and hard) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.
Pt recv vax on 3/26/99; on 3/29/99 pt exp red/ warm vax site, fever (99.5); tx=Ibuprofen, ice packs
Information has been received from a medical assistant concerning a 24 year old female with no pertinent medical history and no drug reactions/allergies who in 1983 and 1991 was vaccinated with the first and second dose of MMR II. Subsequently the patient has not seroconverted for the measles component of the vaccine. This was discovered during routine blood work to check immunization titers. No other information was available at that time. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Diffuse nerve and muscle pain; Diffuse nerve and muscle pain; This case was reported by a consumer via interactive digital media and described the occurrence of muscle pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced muscle pain and nerve pain. On an unknown date, the outcome of the muscle pain and nerve pain were unknown.   It was unknown if the reporter considered the muscle pain and nerve pain to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was selected as an adult as per vaccine indication. The age at vaccination was not reported. The patient experienced diffuse nerve and muscle pain after the Shingrix vaccine. The follow-up would not possible as no contact details were available.
immediately after vaccination had flushed feeling. dizziness, and "jittery. diarrhea started 18 hrs after
Very mild:  headache, sore arm, fatigue  All three so mild as to be almost not noticeable.  No other effects from vaccination
Red, swollen, watery eyes; scratchy throat, hoarseness. Similar reaction last year, but not as bad (also 20 + yrs ago).
Quarter size red knot on left leg at vaccination site.  Swelling and firm lump under skin 8 days after receiving vaccination.